Loading Page
Dr. Prakash Satwani, MD is a physician provider in New York, NY specializing in physician and pediatric hematology/oncology. He graduated from Grant Medical College. Dr. Prakash Satwani, MD is affiliated with NewYork-Presbyterian, ColumbiaDoctors and CUIMC/NewYork-Presbyterian Morgan Stanley Children's Hospital.
Dr. Prakash Satwani, MD graduated from Grant Medical College. He completed residency at The Brooklyn Hospital Center. He is certified by the Board Certification: pediatric hematology-oncology and has a state license in New York.
Medical School: Grant Medical College
Residency: The Brooklyn Hospital Center
Board Certification: Board Certification: pediatric hematology-oncology
Licensed In: New York
Dr. Prakash Satwani, MD appears to accept the following insurance providers: VNSNY CHOICE, CIGNA, Healthspring (Cigna Medicare), Local 1199, Empire Blue Cross/Blue Shield, Emblem/GHI, ElderServe, Medicare, Affinity Health Plan, Amida Care, UnitedHealthcare, Empire Blue Cross Blue Shield Healthplus, Emblem/Hip, Fidelis Care, MVP Health Care, WellCare, World Trade Center Health Plan, Magnacare (National), AETNA, Multiplan, Healthfirst, MultiPlan, United Healthcare PPO, United Healthcare POS, United Healthcare HMO, Aetna POS, MVP Health Care, MagnaCare, Vytra, Great-West Healthcare, Healthfirst, Aetna EPO, Aetna PPO, Aetna HMO, GHI PPO, Group Health Incorporated (GHI), Aetna Signature Administrators, CIGNA PPO, CIGNA POS, CIGNA HMO, CIGNA EPO, EmblemHealth, WellCare, Medicaid Managed Care, Blue Shield PPO, Blue Shield HMO, Blue Shield EPO, HealthSpring, UnitedHealthcare, Affinity Health Plan, United Healthcare, Medicare, Medicaid, Railroad Medicare, Cigna, 1199SEIU, Oxford HMO, Fidelis Care, HIP PPO, HIP POS, HIP EPO, HIP HMO, Empire BlueCross BlueShield HMO, Empire BlueCross BlueShield PPO, Empire BlueCross BlueShield, Aetna, Healthfirst - Leaf (Exchange), ElderServe - Special Needs, AETNA - Student Health, MVP Health Care - Child/Family Health Plus, Healthfirst - Child/Family Health Plus, Empire Blue Cross - EPO, AETNA - NY Signature, Amida Care - Special Needs, AETNA - Medicare Managed Care, Healthfirst - Medicare Managed Care, VNSNY CHOICE - SelectHealth, VNSNY CHOICE - Medicare Managed Care, MVP Health Care - Essential Plan, World Trade Center Health Plan - World Trade Center Health Plan, Medicare - Traditional Medicare, VNSNY CHOICE - Special Needs and MVP Health Care - HMO.
According to our sources, Dr. Prakash Satwani, MD accepts the following insurance providers:
Dr. Prakash Satwani, MD does not have any reviews yet, be the first to leave a review of Dr. Prakash Satwani, MD here: Leave a Review
These charts describe general payments received by Dr. Prakash Satwani, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$39,044
GAMIFANT $39,044 |
|||
|
$8,845
Ryoncil $8,845 |
|||
|
$6,137
Defitelio $2,477 |
Erwinaze $266 |
$3,395 |
|
|
$1,458
KYMRIAH $1,058 |
$400 |
||
|
$164
LYFGENIA $164 |
|||
|
$187
clonoSEQ $64 |
$122 |
| $28,166 | |
| $14,950 | |
| $4,500 | |
| $4,392 | |
| $3,808 | |
| $19 |
Dr. Prakash Satwani, MD has received 33 research payments totaling $115,511.
Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment.
